Complement polymorphisms have been shown to be important in genome-wide studies of RA patients; a C5 polymorphism functionally resulted in more efficient cleavage into the proinflammatory anaphylotoxin C5a (Korczowska, 2014). The gene discussed is C5AR1; the disease is rheumatoid arthritis.